Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
601 questions in 75 reviews · Schizophrenia
current versionsNo studies 601 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
CANNABIS REDUCTION: ADJUNCT PSYCHOLOGICAL THERAPY vs TREATMENT Adverse effects: no clinically important adverse effects ‐ medium term ‐ not measured · patients with SCHIZOPHRENIA AND CANNABIS USE Cannabis and schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
CANNABIS REDUCTION: ADJUNCT PSYCHOLOGICAL THERAPY vs TREATMENT Leaving the study early ‐ medium term ‐ not reported · patients with SCHIZOPHRENIA AND CANNABIS USE Cannabis and schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
CANNABIS REDUCTION: ADJUNCT PSYCHOLOGICAL THERAPY vs TREATMENT Satisfaction with treatment ‐ medium term ‐ not measured · patients with SCHIZOPHRENIA AND CANNABIS USE Cannabis and schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE added to LOW DOSE ANTIPSYCHOTICS vs STANDARD DOSE ANTIPSYCHOTICS Service outcomes: Hospitalisation · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE added to LOW DOSE ANTIPSYCHOTICS vs STANDARD DOSE ANTIPSYCHOTICS Quality of life: No clinically important change in quality of life · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE added to LOW DOSE ANTIPSYCHOTICS vs STANDARD DOSE ANTIPSYCHOTICS Economic outcomes: Cost of care · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE vs STANDARD DOSE ANTIPSYCHOTICS Service outcomes: Hospitalisation · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE vs STANDARD DOSE ANTIPSYCHOTICS Quality of life: No clinically important change in quality of life · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE vs STANDARD DOSE ANTIPSYCHOTICS Economic outcomes: Cost of care · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE added to TCM DRUG vs TCM DRUG Mental state: No clinically important change in mental state · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE added to TCM DRUG vs TCM DRUG Service outcomes: Hospitalisation · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE added to TCM DRUG vs TCM DRUG Quality of life: No clinically important change in quality of life · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE added to TCM DRUG vs TCM DRUG Economic outcomes: Cost of care · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE vs TCM DRUG Mental state: No clinically important change in general mental state · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE vs TCM DRUG Service outcomes: Hospitalisation · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE vs TCM DRUG Adverse effects: Clinically important general adverse effects · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE vs TCM DRUG Quality of life: No clinically important change in quality of life · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE vs TCM DRUG Economic outcomes: Cost of care · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ELECTRIC ACUPUNCTURE CONVULSIVE THERAPY vs ELECTROCONVULSIVE THERAPY Global state: Relapse · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ELECTRIC ACUPUNCTURE CONVULSIVE THERAPY vs ELECTROCONVULSIVE THERAPY Mental state: No clinically important change in general mental state · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ELECTRIC ACUPUNCTURE CONVULSIVE THERAPY vs ELECTROCONVULSIVE THERAPY Service outcomes: Hospitalisation · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ELECTRIC ACUPUNCTURE CONVULSIVE THERAPY vs ELECTROCONVULSIVE THERAPY Quality of life: No clinically important change in quality of life · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ELECTRIC ACUPUNCTURE CONVULSIVE THERAPY vs ELECTROCONVULSIVE THERAPY Economic outcomes: Cost of care · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE added to STANDARD DOSE ANTIPSYCHOTICS vs STANDARD DOSE ANTIPSYCHOTICS Quality of life: No clinically important change in quality of life · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
ACUPUNCTURE added to STANDARD DOSE ANTIPSYCHOTICS vs STANDARD DOSE ANTIPSYCHOTICS Economic outcomes: Cost of care · patients with schizophrenia Acupuncture for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
COMPARISON 2. ARIPIPRAZOLE vs QUETIAPINE General functioning ‐ not measured · patients with schizophrenia Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
COMPARISON 2. ARIPIPRAZOLE vs QUETIAPINE Service use ‐ not measured · patients with schizophrenia Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
COMPARISON 3. ARIPIPRAZOLE vs RISPERIDONE Quality of life ‐ not measured · patients with schizophrenia Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
COMPARISON 3. ARIPIPRAZOLE vs RISPERIDONE General functioning ‐ not measured · patients with schizophrenia Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
COMPARISON 3. ARIPIPRAZOLE vs RISPERIDONE Service use ‐ not measured · patients with schizophrenia Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
COMPARISON 4. ARIPIPRAZOLE vs ZIPRASIDONE Quality of life ‐ not measured · patients with schizophrenia Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
COMPARISON 4. ARIPIPRAZOLE vs ZIPRASIDONE General functioning ‐ not measured · patients with schizophrenia Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
COMPARISON 4. ARIPIPRAZOLE vs ZIPRASIDONE Service use ‐ not measured · patients with schizophrenia Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
COMPARISON 5. ARIPIPRAZOLE vs OLANZAPINE General functioning ‐ not measured · patients with schizophrenia Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
COMPARISON 5. ARIPIPRAZOLE vs OLANZAPINE Service use ‐ not measured · patients with schizophrenia Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
COMPARISON 1. ARIPIPRAZOLE vs CLOZAPINE General functioning ‐ not measured · patients with schizophrenia Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
COMPARISON 1. ARIPIPRAZOLE vs CLOZAPINE Service use ‐ not measured · patients with schizophrenia Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
Pericyazine vs Atypical antipsychotic Mental state not reported · patients with schizophrenia Pericyazine for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
Pericyazine vs Atypical antipsychotic Behaviour not reported · patients with schizophrenia Pericyazine for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
Pericyazine vs Atypical antipsychotic Economic outcomes not reported · patients with schizophrenia Pericyazine for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
Pericyazine vs Typical antipsychotic Mental state not reported · patients with schizophrenia Pericyazine for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
Pericyazine vs Typical antipsychotic Behaviour not reported · patients with schizophrenia Pericyazine for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
Pericyazine vs Typical antipsychotic Economic outcomes not reported · patients with schizophrenia Pericyazine for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
SULPIRIDE vs PLACEBO Global state: clinically significant response in global state ‐ by long term ‐ not measured · people with schizophrenia Sulpiride versus placebo for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
SULPIRIDE vs PLACEBO Mental state: average score for depressive and anxious symptoms ‐ by medium term ‐ not measured · people with schizophrenia Sulpiride versus placebo for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
SULPIRIDE vs PLACEBO Quality of life: average score ‐ by long term ‐ not measured · people with schizophrenia Sulpiride versus placebo for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
SULPIRIDE vs PLACEBO Severe adverse effects ‐ medium term ‐ not reported · people with schizophrenia Sulpiride versus placebo for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
SULPIRIDE vs PLACEBO Safety assessments ‐ medium term ‐ not measured · people with schizophrenia Sulpiride versus placebo for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
PHYSICAL HEALTH ADVICE vs STANDARD CARE Physicl health awareness ‐ not reported · patients with people with serious mental illness General physical health advice for people with serious mental illness (2014) · Cochrane | no estimate extracted | NR | No studies |
HEALTH EDUCATION vs HEALTH EMPOWERMENT EDUCATION Economic ‐ not reported · people with serious mental illness General physical health advice for people with serious mental illness (2014) · Cochrane | no estimate extracted | NR | No studies |